Consun Pharmaceutical Group (HKG:1681) reported a profit attributable to the owners of 399.8 million yuan for the six months ended June 30, up 15% from 347.9 million in the previous year, according to a Wednesday filing with the Hong Kong bourse.
Earnings per share were 0.4930 yuan per share, up from 0.4367 yuan in the prior-year period.
Revenue for the first half was 1.27 billion yuan, up 13% from 1.12 billion yuan in the year-ago period.
The company proposed an interim dividend of HK$0.003.
Shares of the pharmaceutical firm were up by 7% in recent trading.
Price (HKD): $6.03, Change: $+0.42, Percent Change: +7.49%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments